117 related articles for article (PubMed ID: 8438381)
1. Drug development and testing in relation to cell migration and chimerism.
Starzl TE; Murase N; Demetris AJ; Giorda R; Valdivia L; Trucco M
Transplant Proc; 1993 Feb; 25(1 Pt 1):469-72. PubMed ID: 8438381
[No Abstract] [Full Text] [Related]
2. Continuous administration of methyldeoxyspergualin prolongs xenograft survival in hamster-to-rat cardiac transplantation.
Suzuki S; Nishimori H; Kido K; Arita S; Tashiro H; Ohdan H; Quiñones D; Amemiya H
Transplant Proc; 1993 Feb; 25(1 Pt 1):430-1. PubMed ID: 8438365
[No Abstract] [Full Text] [Related]
3. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
[No Abstract] [Full Text] [Related]
4. Induction of human chimerism and functional suppressor cells in fetal pigs: feasibility of surrogate tolerogenesis for xenotransplantation.
Beschorner WE; Qian Z; Mattei P; Hess AD; Colombani PM; Sciscione AC; Khouzami A; Blakemore KJ; Burdick JF
Transplant Proc; 1996 Apr; 28(2):648-9. PubMed ID: 8623323
[No Abstract] [Full Text] [Related]
5. 15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):778-80. PubMed ID: 8438478
[No Abstract] [Full Text] [Related]
6. The increasing complexity of understanding rejection.
Hall BM
Curr Opin Organ Transplant; 2009 Feb; 14(1):1-3. PubMed ID: 19337138
[No Abstract] [Full Text] [Related]
7. Effect of 15-deoxyspergualin in islet xenograft rejection.
Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
[No Abstract] [Full Text] [Related]
8. TLI induces specific B-cell unresponsiveness and long-term monkey heart xenograft survival in cyclosporine-treated baboons.
Norin AJ; Roslin MS; Panza A; Coons MS; Chen CK; Kim YD; Strashun A; Cunningham JN; Tranbaugh RF
Transplant Proc; 1992 Apr; 24(2):508-10. PubMed ID: 1566408
[No Abstract] [Full Text] [Related]
9. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
[TBL] [Abstract][Full Text] [Related]
10. Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease.
Vossen JM; van Leeuwen JE; van Tol MJ; Joosten AM; van den Berg H; Gerritsen EJ; Haraldsson A; Khan PM
Immunodeficiency; 1993; 4(1-4):311-3. PubMed ID: 8167724
[No Abstract] [Full Text] [Related]
11. Xenogeneic cellular response of human lymphocytes to porcine lymphocytes and isolated porcine pancreatic islets.
Heiser A; Ulrichs K; Eckstein V; Müller-Ruchholtz W
Transplant Proc; 1992 Dec; 24(6):2881-2. PubMed ID: 1465982
[No Abstract] [Full Text] [Related]
12. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival.
Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H
Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636
[No Abstract] [Full Text] [Related]
13. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
Starzl TE; Demetris AJ; Murase N; Thomson AW; Trucco M; Ricordi C
Trends Pharmacol Sci; 1993 May; 14(5):217-23. PubMed ID: 8212319
[TBL] [Abstract][Full Text] [Related]
14. Graft adaptation in hamster-to-rat cardiac xenografts.
Hasan RI; Sriwatanawangosa V; Wallwork J; White DJ
Transplant Proc; 1994 Jun; 26(3):1282-3. PubMed ID: 8029909
[No Abstract] [Full Text] [Related]
15. Chimerism in survivors following allograft renal transplantation.
Lee JM; Lee CJ; Hu CY; Hsieh RP; Hu RH; Lee PH; Luh SP; Lee YC; Chu SH
Transplant Proc; 1996 Jun; 28(3):1285-7. PubMed ID: 8658662
[No Abstract] [Full Text] [Related]
16. Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals.
Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA
Transplant Proc; 1996 Apr; 28(2):920-1. PubMed ID: 8623463
[No Abstract] [Full Text] [Related]
17. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
[No Abstract] [Full Text] [Related]
19. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
Starzl TE; Demetris AJ; Murase N; Thomson AW; Trucco M; Ricordi C
Immunol Today; 1993 Jun; 14(6):326-32. PubMed ID: 8397774
[TBL] [Abstract][Full Text] [Related]
20. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
Lin Y; Vandeputte M; Waer M
Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
